15th April 2019

UCI statement on Jarlinson Pantano Gomez

The Union Cycliste Internationale (UCI) announces that the Colombian rider Jarlinson Pantano Gomez was notified of an Adverse Analytical Finding (AAF) of Erythropoietin in a sample collected during an out-of-competition control on 26 February 2019. The control was planned and carried out by the Cycling Anti-Doping Foundation (CADF), the independent body mandated by the UCI, in charge of defining and implementing the anti-doping strategy in cycling.

The rider has the right to request and attend the analysis of the B sample. In accordance with UCI Anti-Doping Rules, the rider has been provisionally suspended until the adjudication of the affair. At this stage of the procedure, the UCI will not comment any further on this matter.

• This media release was published by the International Cycling Union (UCI) on 15 April 2019. Click here for the original.

You may also like...

Pin It on Pinterest

Share This